Lauren Altman, Lieberman
Lauren Altman, Senior Vice President, Lieberman
Lauren has extensive experience in the healthcare sector. She began her career in pharmaceutical advertising, working on the launch of new medications in several therapeutics areas. She currently combines this experience with her educational background in research methods to service many of our healthcare clients.
Lauren has been with Lieberman for over 7 years, and currently manages some of the company’s largest global studies. Her expertise spans most therapeutic categories. She holds a BS in Biometry and Statistics from Cornell University.
Renata Alves, Pfizer
Renata Alves, Director, Business Analytics and Insights, Latin America Vaccines/Oncology Lead, Pfizer
• Business Analytics Lead for Rare Diseases US with Pfizer
• 15 years in the Pharma Industry
Previous Roles Include:
• Specialty Care Business Analytics
• Business development for Astra Zeneca Mexico
• Strategic consultancy for start-up pharmaceutical company in Portugal
• 4 years of Regulatory Affairs experience working for the biologics division of Aventis
• MBA from MIT SLOAN School of Business majoring in Health Care and Marketing with a minor in International Business
• BA in Publicity and Advertising from Universidade Federal Fluminense, Brazil
• BA in Journalism from Universidade Federal Fluminense
Jill Ambrogio, Janssen
Jill Ambrogio, Director, Market Research Excellence, Janssen
Jill Ambrogio has extensive experience in the pharmaceutical and marketing research industry. She is currently the Director of Market Research Excellence at GCSO (Global Commercial Strategy Organization) at Janssen responsible for driving functional excellence in market research, championing talent, and building best practices across the organization. Her last position was a Product Director on the Xarelto Brand Team, responsible for developing strategy and tactics for the Long Term Care (LTC) channel and the Xarelto and Janssen CarePath support programs. Jill has held several roles in both the global and US organizations at Janssen, as well as various positions at EMD Serono, Bayer, and Boehringer Ingelheim.
Jonathan Asher, PRS IN VIVO
Jonathan Asher, Executive Vice President, PRS IN VIVO
As Executive Vice President at PRS IN VIVO, the world’s leading shopper and packaging research firm, Jonathan manages several client relationships, supervises the Account Executive group and oversees the firm’s marketing efforts.
Asher has over thirty years’ experience in both marketing research and brand design for consumer packaged goods.
A frequent speaker and lecturer on topics pertaining to marketing and design, Jonathan has been quoted in major publications, including Fortune, The New York Times, The Wall Street Journal, Brandweek, Advertising Age and Brand Packaging. Jonathan has appeared on “ABC World News Tonight,” the “CBS Evening News,” “CNN Headline News,” “Fox Network News,” NBC’s “Today” show, ABC Radio and CNBC’s “On The Money.” He is also a faculty member of the Path To Purchase Institute.
Steve Bell, AplusA Bell Falla
Steve Bell, Senior Partner, AplusA Bell Falla
Steve Bell is a statistician and consultant specializing in pharmaceutical markets and quantitative marketing research methods. Steve has applied his statistical and software development background to create several original quantitative methods tailored to the needs of pharmaceutical marketers. From 1989—1998, Steve was an Assistant Professor of Marketing at the Stern School of Business, New York University. From 2002—2016, together with Juan Falla, Steve was a Founder and Senior Partner of Bell Falla. Since June 2016, Steve has been Senior Partner of AplusA Bell Falla. Steve has a B.A. from Davidson College, M.S. from Texas A&M University, and an MBA and Ph.D. from Columbia University.
Nilesh Bhutada, Takeda Pharmaceuticals
Nilesh Bhutada, Ph.D., Senior Analyst, Takeda Pharmaceuticals
Nilesh Bhutada is a Senior Analyst of Market Research at Takeda Pharmaceuticals. In this role, Nilesh is responsible for recommending, designing, and executing qualitative and quantitative primary market research to provide actionable information and insights that drives evidence-based strategic and tactical organizational decisions. Prior to joining Takeda Pharmaceuticals, Nilesh worked as Assistant Professor of Social and Administrative Pharmacy at the California Northstate University College of Pharmacy, Elk Grove, CA, where he taught pharmacy administration and pharmacy communications to PharmD students, and conducted primary market research in direct-to-consumer advertising of prescription drugs, consumer behavior, disease awareness advertising, medication adherence, and student learning assessment. He has received numerous awards recognizing his contributions to scholarship and research. His work has been published in several national and international peer-reviewed journals. Nilesh earned his PhD in Pharmacy Care Administration from The University of Georgia, Athens, USA.
Terri Boyd, Johnson & Johnson
Terri Boyd, Procurement, Market Research, Johnson & Johnson
Prior to joining Procurement, Terri held several roles within Business Analytics/Market Research for 19 years. Her Market Research experience spans both medical devices and pharmaceuticals. During her 19 year tenure at J&J, Terri spent 4 years at Cordis providing both Market Research and initiating a Competitive Intelligence department, another 4 years at Ortho Biotech conducting both primary and secondary research and 7 years at Tibotec Therapeutics managing Market Research, Competitive Intelligence and Sales Operations.
Prior to joining Johnson & Johnson, Terri was employed by Hoechst Roussel Pharmaceuticals (now Sanofi Aventis) where she was the Director of Market Research/Analytics. Before moving into the Pharmaceutical side of the world, Terri was an Account Representative for IMS Health. Terri’s current role in Procurement blends her knowledge of Market Research and her relationships with the suppliers to bring value to her business partners.
Caroline Brennan, Market Strategies International
Caroline Brennan, Vice President, Life Sciences, Market Strategies International
Caroline has more than 20 years of market research experience and is known for her expertise in advanced analytics.
Initially joining Market Strategies in 2005, Caroline works closely with key pharmaceutical clients, addressing their business concerns across therapeutic areas and stages of product development. She has expertise with a variety of methodologies, including segmentation studies, discrete choice modeling and consumer experience modeling.
Prior to rejoining Market Strategies in 2016, Caroline worked for 3 years at Attitude Measurement Corporation leading custom research projects for key players in the healthcare market. She has also directed the Marketing Analytics Department of Cadient Group and was responsible for tracking the success of pharmaceutical firms’ online marketing initiatives. She began her market research career at ARBOR Inc. (now part of GfK), directing research projects for leaders in the food and beverage industries.
Caroline earned her doctorate in social psychology from the University of Notre Dame and a bachelor’s degree in psychology from Franklin and Marshall College.
Amanda Buonopane, Segmedica
Amanda Buonopane, Research Director, Segmedica
Amanda Buonopane, MA, is a Ph.D. candidate in Cultural Anthropology. She specializes in ethnographic research and has over 10 years of experience conducting international as well as domestic qualitative research. Prior to working for Segmedica Amanda worked as an adjunct professor at several universities in Western New York, teaching social science topics, including qualitative research methods. As lead researcher, she applies her ethnographic and qualitative interviewing expertise to gain insightful feedback that gets to the root of specified business objectives.
Laura Radosh Butt, LBR Insight
Laura Radosh Butt, Managing Director, LBR Insight
Laura Radosh Butt formed LBR Insight in 2006 after years of leading strategic planning efforts at top advertising agencies, such as McCann, J. Walter Thompson and Deutsch. At these agencies, not only was Laura accountable for turning research insights into action and moderating qualitative research on a variety of topics, but she also helped to build their current healthcare marketing departments that many of you may work with everyday. Laura has moderated hundreds upon hundreds of healthcare discussions with both patients and HCPs for many top-rated Pharmaceutical companies. She is a graduate of the University of Pennsylvania and is a RIVA trained moderator.
Lillian Cao, Taiho Oncology Inc.
Lillian Cao, Director, New Product Planning, Taiho Oncology, Inc.
Lillian Cao is a marketing, strategic planning, and commercial effectiveness leader recognized for excellent collaboration, communication, and business analysis skills, with a track record of accelerating business growth in complex and challenging environments. In her current role as a Director of New Product Planning, she provides commercial insights and enables sound strategic decisions for pipeline assets and US licensing opportunities.
Lillian has more than 14 years of experiences working with primary care, specialty, and orphan drug products. Her experiences in forecasting, market research, sales effectiveness, in-line brand marketing, and new product commercialization shaped her perspective on market researches. Before moving to pharmaceutical companies, she was also a management consultant with The Boston Consulting Group (BCG), developing sales and marketing strategies for pharmaceuticals, consumer goods, high tech, and financial services companies.
Lillian holds an MBA from The Stanford Graduate School of Business and a B.A. from Fudan University.
Fred Church, SKIM
Fred Church, Director, Healthcare, SKIM
Fred has specialized in quantitative pharmaceutical marketing research for more than 15 years. He is known as an expert in forecasting return-on-investment for pharmaceutical direct-to-consumer (DTC) advertising campaigns, and has spoken widely on this topic at industry events and conferences. Prior to his current position at SKIM, Fred played an instrumental role in developing pharmaceutical forecasting initiatives at Ipsos and Nielsen. He holds a B.A. in Sociology from Northwestern University.
Lisa Courtade, Merck
Lisa Courtade, Executive Director, Global Customer & Brand Insights, Merck
A strategic, solutions oriented business leader with over 20 years of success in delivering customer insights that drive business results, Lisa has a passion for the healthcare industry and for the patients we serve. Lisa Courtade currently leads executional excellence and the transformation of insights generation at Merck as the Executive Director of Global Market Research Excellence. In this role, she and her team are responsible for driving business results and creating customer value by delivering value based innovation. Lisa was an early adopter of engaging patients in marketing research and leveraging CPG methodologies in the pharma space which contributed to receipt of the ARF’s David Ogilvy Award for creative use of insights in celebrate breakthrough moments when creative inspiration and research insights come together to produce a spectacular advertising campaign.
Lisa lives her passion for shaping the future of the industry by serving on the Marketing Research Institute International Board (MRII) as Chair of the Pharma Curriculum Committee and as an Advisory Board & Steering Committee member for the University of Georgia’s Masters in Marketing Research program, where she also serves as an alumni mentor. Lisa is an active member of the Healthcare Businesswoman’s Association (HBA) where she chaired Career Development and served as the first Global Research Director.
Bob Cuneo, Brädo Creative Insight
Bob Cuneo, President & Chief Creative Officer, Brädo Creative Insight
Bob started his career as an art director in the ad agency business – ultimately moving on to become a Creative Director at DMB&B and the Executive Creative Director at Glennon. He’s won creative awards for numerous brands, including Budweiser, Michelob, Skittles, Wear-Dated Carpet, Round-Up and Puppy Chow. Believing that most research approaches stymied creativity versus inspiring it, Bob founded Brädo Cuneo. After a few years, Bob teamed with his lifelong friend, Steve Nollau, to form Brädo Creative Insight. Cuneo believes the creativity required to provide transformational insight far exceeds the demands of his creative director role.
Renu Dalal, Phoenix Marketing International
Renu Dalal, Vice President, Client Services, Phoenix Marketing International
Amalia De Luca, Lifescience Dynamics
Amalia De Luca, Ph.D., Consultant, Lifescience Dynamics
Amalia is based in the London office as a consultant. She is involved in market research, competitive intelligence and market access consulting projects across various therapeutic areas including oncology, rheumatology and inflammatory diseases. She is also experienced in medical devices and diagnostics. As a consultant at Lifescience Dynamics, she works as a part of a team committed to helping develop executable strategies for clients around the globe and she is a full member of the client engagement team.
Amalia, whose native language is Italian, is also fluent in English. She works closely with the Italian market.
She holds a PhD in Bioengineering applied to cardiovascular sciences from Imperial College London, where she took part in a multidisciplinary project investigating the causes of atherosclerosis. She also holds a BSc and MSc in Medical Engineering from the University of Rome.
Outside of work, Amalia enjoys travelling and discovering new cultures. She is also a food lover and cannot turn down a glass of good Italian wine.
Tim Deckman, RG+A
Tim Deckman, Vice President and Chief Marketing Scientist, RG+A
Dr. Deckman is responsible for executing all phases of RG+A’s advanced and proprietary methodologies, serving as a methodological expert for clients as well as internal teams. Tim works to ensure that RG+A maximizes the accuracy and amount of actionable insights provided to clients from the data collected.
Tim worked at RG+A from 2012 to 2014 as a research analyst and research manager. In these positions he assisted with proposal development, wrote survey instruments, conducted analyses, and wrote final reports. Tim rejoined the RG+A team in June of 2015 as Associate Methodologist and has since secured the role of Vice President and Chief Marketing Scientist. In his new role, Tim is able to continue to leverage his background in experimental design and advanced statistics to help design projects, execute advanced analytics, train junior staff, and convey complex analyses and results to non-technical audiences.
Tim has experience executing quantitative and qualitative studies both domestically and internationally. Tim has gained valuable experience conducting market research projects across multiple therapeutic areas, including: oncology, blood disorders, psychological disorders, cardiovascular disorders, as well as orphan conditions.
Tim holds a B.S. in Psychology from St. Lawrence University and a M.S. and Ph.D. in Experimental Psychology from the University of Kentucky.
Barbara Deradorian, Phoenix Marketing International
Barbara Deradorian, Executive Vice President, Phoenix Marketing International
Michael Devinoff, Bristol-Myers Squibb
Michael Devinoff, Vice President – Head of Forecasting, Bristol-Myers Squibb
Michael has been with Bristol-Myers Squibb Co. for over 10 years. During his tenure at BMS, Michael has perfected his Marketing Research skills through ever-expanding roles within both the core US Pharmaceuticals and Global Marketing/Commercialization organizations. He has led teams of Marketing Research analysts across various products and therapeutic categories. His extensive efforts within the Cardiovascular group has helped grow the company’s most significant product, Plavix, into the world’s 2nd largest pharmaceutical brand.
Prior to his time with BMS, Michael spent four years with NFO-Migliara/Kaplan Associates, an industry-leading Marketing Research consulting company. There he successfully built a multi-million dollar base of client business and led a broad team of research analysts addressing strategic business questions across products spanning a variety of therapeutic categories and life-cycle stages.
Prior to his nearly 15 year tenure within the marketing research industry, Michael honed his analytical and business skill set through experiences working at Becton Dickenson & Co. (marketing/marketing research), Baskin-Robbins (store management), Curtis 1000 (sales), and Red Robin Restaurants (store management & training).
Michael holds an MBA in Marketing from Rutgers University Graduate School of Management, and a BS in Biology/Genetic Engineering from Binghamton University.
Michael and his family live in the Princeton, NJ area.
Michael Donnelly, Optinose
Michael Donnelly, Head of Insights and Analytics, Optinose
Judy Droar, Ipsen
Judy Droar, Director, Ipsen
Analia de la Fuente, UCB
Analia de la Fuente, Vice President & Global Head of Patient & Ecosystem Insights Practice, UCB
Analia has joined UCB in March 2017 as Head of Patient and Ecosystem Insight Practice, leading global insight generation from discovery stage to product launch up to trends and foresight, capabilities development and best practices.
She started her career in Unilever in Argentina in Consumer and Market Insight for the Homecare categories. Over the following 15 years , she held various regional and global leadership positions in Consumer and Market Insight in Latin America, North America and Europe, across the major brands in Home and Personal Care categories.
In 2013 she joined Mondelez International where she held various leadership positions in the Consumer Insight and Strategy function.
Analia is a sociologist from University of Buenos Aires, she is Argentinean, and recently moved to Brussels with her husband and son.
Joaquin Garcia-Lopez, Janssen
Joaquin Garcia-Lopez, Associate Director, Global Market Research, Janssen
Joaquin is the global market research lead for Alzheimer’s Disease within Janssen’s Global Commercial Strategy Organization. Joaquin’s overarching objective is to maximize the long-term value of Janssen’s global assets and portfolio by shaping strategic business decisions based on actionable insights and recommendations generated through predictive, innovative and integrated analytics.
Prior to joining Janssen, Joaquin served as Vice President in the healthcare team at ORC International, a market research and business intelligence firm. In this role, Joaquin worked with a broad portfolio of clients, including ten of the top 12 global pharmaceutical companies. He led consultative market analytics that met a broad range of business needs, including new product development and indication assessments, patient and HCP insight analysis, lifecycle management strategies, therapy area tracking, competitive landscapes and diverse types of innovative market analyses.
Joaquin started his pharmaceutical career 16 years ago, as a bench engineer at Forticell Bioscience’s process development group, where he had a leading role in a broad range of projects relating to the development and launch of novel cell therapies and advanced biomaterials.
Joaquin graduated from Columbia University with both an MS in Technology Management/Biopharma and a BS in Biomedical Engineering and holds a B.A. in Mathematics from Fordham University.
Ed Geiselhart, Cello Health Insight
Ed Geiselhart, Director, Cello Health Insight
Ed Geiselhart is an accomplished advocate for user-centered design and the power of design thinking to make a meaningful difference in helping clients bring innovation to the market. He has nearly 25 years of consulting experience in the healthcare and pharmaceutical industries, with a focus on connecting user insights with business decisions, marketing strategy, innovation planning, and device design.
Andrea Geppert, Strongbridge Biopharma
Andrea Geppert, Sr. Product Manager, Strongbridge Biopharma
Andrea Geppert is the Senior Product Manager of the Marketing team at Strongbridge Biopharma PLC. After recent research was conducted in Primary Periodic Paralysis (PPP), Andrea took the results and helped drive the creation of the brand’s patient materials for launch, which is most relevant. Prior to Strongbridge Biopharma, Andrea worked in Marketing at CSL Behring. Andrea graduated from Saint Joseph’s University with a degree in pharmaceutical marketing and is currently enrolled at DeSales University for her MBA in Healthcare Systems Management.
Alex Gonzalez, SKIM
Alex Gonzalez, Senior Analyst, Healthcare, SKIM
As a Senior Analyst at SKIM, Alex has extensive experience managing complex, multi-phase research projects for pharmaceutical, consumer health, and animal health clients. He specializes in quantitative methodologies, specifically in forecasting and communications. Alex holds a BA in Health and Societies, with a concentration in Finance, from the University of Pennsylvania.
Ellen Gordon, RG+A
Ellen Gordon, Senior Vice President and Head of Research, RG+A
Dr. Gordon joined RG+A in 2017 as Senior Vice President and Head of Research. In this role, Ellen leads client service and works collaboratively with the research team to execute innovative insights and develop strategic programs across all of RG+A’s client engagements.
Ellen has over 20 years of experience in healthcare and pharmaceutical research. She brings an extensive background in designing and executing strategic research solutions that leverage custom and syndicated pharmaceutical research, utilizing both qualitative and quantitative methodologies in the US and globally. Additionally, she has conducted market research in multiple therapeutic areas, including diabetes, oncology, cardiovascular disease, and rare diseases.
Prior to joining RG+A, Ellen held senior positions at Fulcrum Research Group, ImpactRx and Market Strategies International where her responsibilities included developing and growing global pharmaceutical client practices, introducing iPad-enabled research panels in multiple countries, leading teams responsible for the execution and delivery of both custom and syndicated global market research, generating new business, and moderating physician and patient interviews.
Ellen holds a B.A. in Politics from Brandeis University, an MA in Russian Studies from Georgetown University and a Ph.D. in Political Science from the University of Michigan.
Rebecca Gould, Fulcrum Research Group
Rebecca Gould, Executive Vice President, Fulcrum Research Group
Rebecca has over 10 years of experience in custom market research focused exclusively on the biopharmaceutical / medical device industries. Rebecca enjoys both qualitative moderating and quantitative analysis and excels at leading projects that deliver usable insights. While Rebecca’s clients span a range of therapeutic areas, she has extensive experience working with rare diseases and understanding their unique challenges. Rebecca holds a BA in psychology from Wesleyan University.
Roger Green, RG+A
Roger Green, President/CEO, RG+A
Mr. Green founded RG+A in 1991 and serves as President and Chief Executive Officer. Over the past twenty years, Roger has worked to design marketing research methods, insights, and modeling tools that promote greater understanding of what drives value in pharmaceutical markets. He is the primary developer of Dynamic Practice Simulation® (DPS®), RG+A’s proprietary patient-simulating marketing research system, which has been applied successfully in virtually every major market around the world.
Mr. Green has sat on editorial boards, has written articles and participated in roundtables for leading industry publications, and lectured widely at prominent university programs involved with marketing research and pharmaceutical marketing. He received a BA in political science and an MBA in marketing from Columbia University.
Mr. Green is the 2008 recipient of the R.R. Fordyce Award, an honor bestowed upon leaders in the marketing research industry dedicated to the betterment of the profession.
Stuart Greenberg, Bayer
Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
Glenn Grossman, Sanofi
Glenn Grossman, Global Director of Forecasting and Analytics, Sanofi
Glenn Grossman is Global Director of Forecasting and Analytics for the cardiovascular franchise at Sanofi. For 20 years, he has led teams in advanced patient analytics to generate insights that inform strategy across in-line and pipeline products, managed markets and business development. He has developed and managed advanced methodological approaches and efficient analytical strategies for healthcare research evaluation, optimization & forecasting, for a variety of commercial and government healthcare clients.
Anne Hale, Pfizer
Anne Hale, US BAI I&I Lead, Pfizer
Dr. Hale has been with Pfizer’s market analytics group for 10 years. In addition to this role, she also leads the Center of Excellence for HCPs, which is tasked with identifying innovative, efficient research solutions for business issues and decisions relating to our physician customers. She has held several other positions within Pfizer, including the Market Analytics Team Leader for Urology/Respiratory brands, as well as Global Market Analytics Team Leader for New Product Development for a wide range of therapeutic areas.
Prior to joining Pfizer, Anne was a Marketing Professor at both McGill University in Montreal and the University of Victoria in Victoria, British Columbia, Canada, where she taught such courses as Marketing Management, Marketing Research, Business Statistics, Advertising, and Retail Management at both the undergraduate and graduate levels. In addition, she also served a term as Dean of the Undergraduate Program at both McGill University and the University of Victoria, as well as teaching in the Executive Education Institutes of both universities.
Anne holds a Bachelor of Business Administration, Masters of Business Administration and a Doctorate in Marketing, specializing in quantitative methodology, all from the University of Texas at Austin.
Michael Heasley, Evolution
Michael Heasley, M.A., M.S., Partner & Chief Research Officer, Evolution
Mr. Heasley conducts both quantitative and qualitative research studies, typically concentrating on large complex projects with an international focus. He brings with him to Evolution extensive experience in pharmaceutical marketing research with expertise in the respiratory and allergy, biologic, anti-infective, oncology, and hematology therapeutic areas among others. Most recently, Mr. Heasley worked for a large Pharmaceutical company as a primary marketing researcher in support of launch products. He has an impressive academic background in both math and statistics which he applies to quantitative research projects. He holds masters’ degrees in both Mathematics and Applied Statistics from Villanova University and a bachelor’s in Mathematics from the University of Pennsylvania. Prior to entering the field of marketing research, Mr. Heasley served as a faculty member at several private institutions where he taught a variety of math and statistics courses.
Michael Henrick, Medac Pharma
Michael Henrick, Director Commercial Operations, Medac Pharma
Michael Henrick is the Director of Commercial Operations where he manages the non-financial analytics in both business development and existing products and leads the sales operations functions for Medac’s specialty sales force. Mike has 10 years of experience in small and medium pharma. Prior to Medac, Mike had a series of roles with increased responsibility with Astellas Pharma working across their Hospital, Transplant, and Oncology sales teams developing system-wide view of corporatized customers to show system impacts, key accounts, and prescribers, and the total system value across all products and franchises. Led the development of tools including integration and interpretation of affiliation data.
Dani Heywood, Branding Science
Dani Heywood, President, Branding Science
Dani is originally from the UK, but has been based in the US since 2004, and currently leads the Branding Science US offices. She holds a PhD from Leeds University, UK focused on looking at molecular genetics of vascular disorders. Prior to going agency side, she worked with Unilever in the hair care division for 5 years, where she developed a passion for understanding brands and consumers. Since then she has been focused in growing teams and companies exclusively in global healthcare market research. Oncology, rare diseases and animal health are her main areas of therapy area expertise, and she has experience across the gamut of both qualitative and quantitative methodologies, especially those requiring a high level of creativity.
Jas Kahlon, Janssen
Jas Kahlon, Commercial Insights & Strategy, Consumer Lead, Janssen
Jas Kahlon has over 9 years of experience in market research across consumer packaged goods, consumer goods, and the pharmaceutical industry. Jas is currently the patient research lead for Invokana, managing all consumer research efforts for the US market.
Jas has expertise in advanced analytics, primary research, and strategy development in B2B and B2C. Prior to Janssen, Jas has successfully led projects and managed teams to influence strategy for companies such as Capital One, Clorox, and Carrier Corporation (a UTC Company). He led market research efforts that successfully integrated research into the sales team, implemented processes that helped reduce research turnaround time at lower cost, built processes to link insights to regions in “real-time”, and led identification and development of niche growth opportunities.
Jas holds an MBA in International Business from the Thunderbird School of Global Management and Bachelor’s degree in Business from India.
Kumar Kantheti, Noden Pharma USA Inc.
Kumar Kantheti, Exec. Director, Commercial Insights & Salesforce Operations, Noden Pharma USA Inc.
D’Arcy King, Hall and Partners
D’Arcy King, Ph.D., Global Head of Customer Experience, Hall and Partners
D’Arcy is a behavioral health psychologist who brings health care expertise & methodological rigor to her consulting with pharmaceutical and biotech companies. D’Arcy has worked in the diabetes field for over two decades and is a faculty member in the Department of Medicine at Northwell Health, where she recently completed the human factors segment of an artificial pancreas study and is currently investigating the impact of wearable and app technology on diabetes outcomes.
Prior to joining Hall & Partners in 2017, D’Arcy spent 6 years as the Chief Strategy Officer for Daggerwing Health, a patient-centric marketing agency specializing in activating, educating and supporting patients living with chronic disease. D’Arcy earned her doctorate in Cognitive, Social and Developmental Psychology at the New School for Social Research.
Ken Kirsch, Jazz Pharmaceuticals
Ken Kirsch, Senior Manager, Market Intelligence, Jazz Pharmaceuticals
Ken Kirsch is a Pharmaceutical Market Insights and Brand Strategist who partners with industry thought leaders, marketing executives, and external agencies to bring compelling and actionable insights to guarantee commercial success and optimal positioning. After spending nearly a decade as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin, Ken moved on to the manufacturer side of the industry where he has led US and Global market research, analytics, and forecasting efforts for Oncology and Rare Disease therapies at Wyeth, GSK, and now Jazz Pharmaceuticals.
Ken’s vast experience has embedded in him a passion for delivering hard-hitting insights, and a bedrock belief that market research is “the analytical conscience” of any organization.
Ken holds a BA in Communications and Journalism from Bloomsburg University, and an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University in Philadelphia. He is a published novelist who attends local writers’ workshops and groups whenever he has the time. Ken served six years as an Infantryman in the Pennsylvania Army National Guard and lives in Collegeville, PA with his wife and two daughters.
Michael Kostelansky, Daiichi Sankyo, Inc.
Michael Kostelansky, Director, Global Market Research BD, Daiichi Sankyo, Inc.
Michael Kostelansky currently leads a team responsible for executing market assessments on business development and licensing opportunities under consideration by Daiichi Sankyo. The team’s specific responsibilities include conducting all related market research, analytics, CI, forecasting, as well as, valuation support.
Prior to joining in the BD group in 2013, Michael held a role in Daiichi’s New Products Business Analytics Group supporting a number of oncology pipeline products.
Prior to Daiichi Sankyo, Mike consulted for about 5 years with Easton Associates, a boutique strategic consultancy serving life sciences companies.
Mike obtained a Ph.D. in Chemistry at the University of North Carolina at Chapel Hill, and completed a post-doc at the National Institutes of Health (NIH) as PRAT Fellow. He also received an A.B. in Chemistry from Franklin & Marshall College.
Jami Krueger, Align Technology
Jami Krueger, Global Insights, Align Technology
Jami Krueger is a strategy & global insights professional with over 15+ years helping multi-national corporations develop strong brands, optimize product portfolios, and improve the effectiveness & efficiency of brand marketing plans.
Before joining Align Technology, Jami lead the Consumer Affairs operations, insights, and technology team at Clorox where her team was responsible for providing the best consumer experience to the 25,000 consumers who contact Clorox a month, working to turn dissatisfied consumers into advocates to maintain loyalty and positive WOM.
Previously, Jami managed Global Insights on the Clorox Healthcare account, particularly the surface disinfectants & UV medical device portfolio. In this role, she expanded her strategy & insights experience into the healthcare B2B realm, where she helped her team influence and sell products to large IDN systems.
Jami has also spent time developing Innovation for Clorox’s specialty division, in CPG Brand Insights at Unilever, consulting & sales forecasting for large CPG innovations at Nielsen BASES, and optimizing established brand marketing activities using marketing mix & predictive analytics at M/M/A.
John Lauria, LCN Consulting, Inc.
John Lauria, Co-Founder, LCN Consulting, Inc.
John Lauria is the co-founder of LCN Consulting, Inc. He has over 20 years of life science industry experience working with experts in multiple therapeutic areas with the majority of that time spent in business intelligence. He has extensive knowledge of all facets of assessing the external ecosystem from his roles as a collector, manager, analyst, and executive. John has a MA in Psychology and completed doctoral coursework at Pace University.
Will Leopold, CMI
Will Leopold, Account Director, Life Sciences, CMI
Will brings 8 years of experience managing qualitative and quantitative research projects for domestic and international companies. Prior to joining CMI, Will worked as Senior Research Analyst at Market Strategies International where he led research projects and built client relationships with several top 10 pharmaceutical companies. Will holds expertise in the design and execution (including moderation) of both qualitative and quantitative methodologies. Additionally, he is extremely knowledgeable in the therapeutic areas of CNS, immunology, oncology, among many others. Will holds a Bachelor’s of Science in Business Administration with a double major in Marketing and Business Administration from the University of Central Florida.
Michael Luciano, AstraZeneca
Michael Luciano, Sr. Insight Manager, Respiratory Biologics, AstraZeneca
Michael Luciano is a sales, strategy and marketing professional with over twenty years experience in the BioPharma industry. Michael has diverse therapeutic area exposure with an emphasis in oncology, is an award winning sales leader, and is a highly motivated, team player. He is an excellent communicator with strong customer interfacing skills and has an M.B.A in Marketing.
Scott von Lutcken, Merck
Scott von Lutcken, Director, Global Customer Insights, Merck
Scott von Lutcken leads the Customer Strategy Team for Merck’s Global Market Research Excellence Group. He supports adherence, health literacy and customer engagement. Scott has been an advocate for the customer and patient throughout his career and led numerous projects identifying ways to optimize messaging to customers and patients. Scott joined Merck (Schering-Plough) in 2006, and has worked across several therapeutic areas, supported Sales, and the Chief Medical Office in market research. He received his MBA from Drexel University.
Laura Mace, Lifescience Dynamics
Laura Mace, Ph.D., MBA, Engagement Manager, Lifescience Dynamics
Laura began her career in R&D at GSK in 2005, where she worked to create the manufacturing route for Vilanterol, the ultra-LABA component of Breo / Relvar Ellipta, which launched in 2013. However, after nearly 5 years at the scientific coalface, she decided on a move into the commercial side of pharmaceuticals, completing an MBA and joining Lifescience sales and marketing experts ZS Associates in 2012. At ZS, she tackled questions of sales force optimisation, PRMA via payer research, market research, and Medical Education strategy, at the portfolio level and within oncology, psychiatry and in diabetes. Since 2014, she has been refining her commercial pricing skills at Pearson Ham, a cross-market pricing specialist, and is a recent joiner to Lifescience Dynamics in the Market Access and P&R team.
Laura has a DPhil in synthetic chemistry and an MChem in chemistry from the University of Oxford. Her MBA, for which she was awarded the annual prize for Best Full-Time MBA, was awarded by the Alliance Manchester Business School.
Sudhakar Mandapati, Strategic Research Insights (SRI)
Sudhakar Mandapati, Principal, Strategic Research Insights (SRI)
Steve Martino, M Health
Steve Martino, Co-Managing Partner, M Health
Steve is an award-winning advertising writer and creative director with 30 years of experience in helping marketers recognize opportunities, define strategies and build integrated campaigns in several industries. He began his career at consumer ad agencies working on CPG and automotive accounts. Since 2001 he has been working with global biopharma and healthcare clients. Steve combines a deep understanding of strategy with a highly creative vision.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Justin Masterson, SEEK
Justin Masterson, Innovation Strategist, SEEK
I’m a Senior Brand Strategist, which is a way of saying I have been around long enough see paths forward that may otherwise be obscured.
In college at Miami U I fell in love with storytelling and the depth of human stories via a job working in radio for our NPR station. After years as a feature producer both for radio and video, I was stunned to find that discovering human insights and leveraging their stories to change brands/products was a job. I took that job at SEEK, and have been in love with human-centered innovation ever since.
Julie Mastroserio, Novo Nordisk
Julie Mastroserio, Sr. Manager of Insights Development, Novo Nordisk
Julie Mastroserio has over 20 years’ experience as an insights development professional in the pharmaceutical industry. Currently Sr. Manager, Insights for Novo Nordisk, Inc., Julie primarily supports the insulins portfolio, where she leads physician, direct-to-consumer, and payer research programs. Her prior work experience includes insights and analytics roles for Janssen Pharmaceuticals, Pharmacia, Inc., and Bristol-Myers Squibb, across a broad range of therapeutic areas and channels. While she loves digging into data tables, she’s even more passionate about unearthing the truths that drive human behavior.
Julie holds a BA from Douglass College, Rutgers University, and an MA from The George Washington School of Public and International Affairs.
Keshia Maughn, Decision Resources Group
Keshia Maughn, MPH, DRG Director, Analytics & Operations, Decision Resources Group
Director of Data Scientist with nearly a decade of experience in clinical effectiveness, HEOR and commercial effectiveness research. Results-driven, specializing in the timely completion of custom analytics projects with leadership and hands-on experience leveraging various techniques including econometrics/forecasting, supervised machine learning and predictive modeling.
Richard McCloud, Pfizer
Richard McCloud, Director, Pfizer
Rich McCloud is a Director for Business Analytics and Insights, supporting the Pfizer Biosimilars portfolio and Elelyso. Rich joined Pfizer in 1999 in Global Market Analytics where he held roles supporting project teams including Lyrica, Vfend, Celebrex and Bextra. Rich has over 14 years of pharmaceutical market research and consulting experience. His prior experience includes strategy development, HCP positioning and messaging, DTC campaign development, and forecasting.
Rich joined Genentech in 2007, where he gained biologics and respiratory therapy area experience working on Xolair. He embarked as a consultant, and worked primarily with Eli Lilly where he launched the fibromyalgia indication, and developed the very successful DTC campaigns for the chronic pain and depression indications. Rich returned to New York and Pfizer in 2009 to work on Lyrica, and recently joined the Biosimilars team in 2013.
Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree in market research from University of Georgia. He currently resides in Jersey City, NJ, and is the proud father of his daughter, Lillian.
Vaishali Mokashi, Insync
Vaishali Mokashi, VP Healthcare Practice Lead, Insync
Vaishali Mokashi is a Vice President, Healthcare Practice Lead at Insync, a leading global market research and marketing consulting company dedicated to decoding and designing behaviors for good in the health and wellness industry.
In 8 years at Insync, Vaishali has honed her expertise from both the qualitative and quantitative worlds to deliver innovative, insightful solutions across a spectrum of client business challenges that include integrated journeys, adherence issues, brand loyalty, clinical trial optimization and strategic communications work. As a passionate investigator of human behavior and decision-making, clients value Vaishali’s deep experience and uncanny instinct for unearthing the motivating insights that enable them to forge deeper relationships with their target customers and activate strategically for successful business, and human, impact.
Prior to joining Insync, Vaishali held senior roles within Global Advertising Agencies – DDB, Y&R, IPG and led consumer and healthcare brand engagements for clients such as Procter & Gamble, Standard Chartered Bank, Sony, Johnson & Johnson, Pepsi, Ford, etc. across the globe including Asia, Middle East, North America and the EU. Having lived and worked in five different countries previously, Vaishali currently works and resides in New York.
Tim Mooney, Alnylam Pharmaceuticals
Tim Mooney, Associate Director, Market Insights, Alnylam Pharmaceuticals
Dave Moore, Lilly
Dave Moore, Senior Director, Global Market Research, Lilly
Dave currently leads Lilly’s Global Market Research Core organization. This organization is responsible for processes, capabilities and systems to increase the effectiveness of Lilly’s global market research organization. Dave has held a variety of roles at Eli Lilly and Company including organizational effectiveness, brand marketing, new product planning, business development, sales management, marketing analytics and market research. He has been part of the Lilly Market Research organization for the past eleven years. He is a trustee and active member of Marketing Sciences Institute and a member of CASRO. Dave holds a bachelor of science in Engineering from Purdue University and earned his MBA from the Kelly School of Business at Indiana University. His areas of interest and focus have been on increasing the business impact market research has on the organization.
Suraj Moorthy, EMD Serono, Inc.
Suraj Moorthy, Senior Director, Global Forecasting, EMD Serono, Inc.
Suraj Moorthy is currently part of the Global Business Intelligence group at Merck Serono/EMD Serono. As GBI’s Oncology Key Business Partner, he coordinates the activities of a global team that supports Merck Serono’s oncology and immune-oncology franchise, covering all in-market and pipeline assets, as well as any external business development opportunities. GBI helps analyze worldwide market dynamics and product performance, monitors the competitive landscape and competitor strategy, generates customer insights through market research, helps design and test global branding campaigns, and is responsible for forecasts and evaluations.
Prior to that, Suraj built the Global Forecasting Center of Excellence at Merck Serono. His team helped forecast and evaluate all in-market, pipeline and external asset opportunities for Merck Serono’s portfolio in oncology, immuno-oncology, neurodegenerative disease, immune/inflammation indications, fertility, and associated medical devices.
Suraj joined EMD Serono from Sanofi Oncology, where he was the Senior Commercial Expert on the Oncology Global Strategy and Portfolio Management group, and worked closely with Global Marketing to generate asset valuations for external opportunities, and inform the deal structure for in-licensing and acquisition of external assets. Before that Suraj established and lead the Business Analytics group for Sanofi Oncology, supporting a legacy portfolio, new pipeline products and business development. During his tenure the team helped drive launch preparation activities for five late phase cancer assets. Prior to joining Sanofi, Suraj held positions in the Global Health Outcomes and Business & Commercial Analysis groups of GlaxoSmithKline Oncology, and at ZS Associates.
Suraj has an MBA from the Wharton School of Business, and received a Ph.D. in Biochemistry as a James B Duke Fellow at Duke University. Suraj lives near Boston, MA, with his wife and young son.
Anita Natzkova, Teva Pharmaceutical
Anita Natzkova, Ph.D., Director Research Insights and Market Intelligence, Teva Pharmaceutical
• Leads primary and secondary MR for the MS, Cardio-vascular Metabolic, Oncology TAs and Company Branded Generics and delivers Insights for strategic decisions (Reporting, Marketing Plans, AOP or LRP) to internal customers: Marketing, Portfolio, Pricing & Reimbursement departments
• Works with Country stakeholders to produce high business impact insight studies that aim to drive growth
• Determines industry trends (competitors) in Growth Markets and highlights opportunities or threats to TA leads using comprehensive reporting
• Forecasting for pipeline products
Tom Nolte, Research Partnership
Tom Nolte, Director and Head of Business Analytics, Research Partnership
Tom Nolte is a Director and Head of Business Analytics based in the Philadelphia office. He is a strategist in market research-based global initiatives, corporate direction and portfolio strategy with extensive experience in the life sciences and education. He has an emphasis in innovation and strategic market analytics in areas such as product opportunity, proof of concept, positioning and advanced analytics. Tom has been working in the pharmaceutical and medical device industries for more than 25 years. Tom is also a senior consultant at the University of Pennsylvania in early-stage healthcare commercialization and innovation, and is a frequent lecturer in quantitative research approaches.
Angela Olivier, Verilogue
Angela Olivier, Director, Client Services, Verilogue
Angela Olivier is Director within the Client Services team at Verilogue and leads a team of Linguists who analyze over 120,000 exam room conversations with the goal of improving Healthcare Communication. Angela bring over a 13 years of experience within Healthcare Marketing and employs those skills to bring clients the best possible solutions to address their business challenges. Angela takes a strategic approach to problem solving and uses every opportunity to utilize the exam conversation to highlight and identify opportunities for brand teams and market research teams.
Jigisha Pathakji, Bristol-Myers Squibb
Jigisha Pathakji, Director, Customer Insights, Bristol-Myers Squibb
Ms. Jigisha Pathakji is currently the market research lead for OPDIVO® at Bristol-Myers Squibb, responsible for the lung cancer, head and neck, and biomarker indications. Jigisha has over a decade of Global and US experience leading marketing research in the pharmaceutical industry through all phases of product development.
Jigisha has successfully launched three extremely critical specialty brands for Bristol-Myers Squibb, OPDIVO® (Nivolumab), YERVOY® (Ipilumimab) and ORENCIA® (Abatacept). In addition, she has led market research, identifying competitive market threats on Eliquis and recommended solutions that turned around brand performance. Jigisha was selected in 2015 to serve on the prestige market research executive board of the Rutgers Business School.
Prior to joining Bristol-Myers Squibb, Jigisha conducted market research within the consumer-packaged goods industry for Kraft Foods Inc. specialized candy business (Altoids® and Life Savers®). Jigisha led the market research plan to successfully position and advertise Creme Savers®, a lead product for the franchise.
Jigisha holds an MBA from Cornell University, from the Johnson School of Business and a Bachelor’s of Science from Cornell University in Management Economics. She was Captain of the Division 1, Varsity tennis team leading the team to the first ever NCAA tournament. She currently lives near Princeton and enjoys being active outdoors, reading and spending time with family and friends.
Kathleen Pearson, Lilly
Kathleen Pearson, Senior Director Lilly Market Research, Lilly
Kathleen leads the Market Research function for Eli Lilly’s Biomedicines Business Unit where she serves as Senior Director. Kathleen is a market research professional with over twenty years marketing and primary market research experience. Prior to Lilly, she directed an agency team dedicated to global consumer and business-to-business research for large multi-national clients. In the industry, she is best known for her work supporting Oncology business intelligence and for the development of competencies for market research talent. She is recognized for her ability to develop associates’ technical and transferable skills, earning her Lilly’s prestigious “Manager of Choice” award. Kathleen graduated magna cum laude from DePauw University and earned her M.B.A. from the Kelly School of Business at Indiana University. Kathleen previously served on the executive board of the Pharmaceutical Business Intelligence Research Group, holding the office of Vice President, Primary Research.
Married with two children, she enjoys cooking, home improvement, biking, and reading.
Adelene Perkins, Infinity Pharmaceuticals
Adelene Perkins, Chair, President and CEO, Infinity Pharmaceuticals
Adelene Perkins serves as Infinity’s Chief Executive Officer and Infinity’s Chair. She was named CEO and elected to the Board of Directors in 2009. Ms. Perkins joined Infinity in 2002 and served as Infinity’s President, Executive Vice President and Chief Business Officer before being named CEO.
Ms. Perkins joined Infinity from TransForm Pharmaceuticals as an early member of the management team that built the company prior to its acquisition by J&J. From 1992-1999, she was at Genetics Institute, now a unit of Pfizer, where she was vice president of emerging businesses and the cofounder and general manager of the DiscoverEase™ business unit. She also formed and served as chief executive officer of MetaMorphix, a joint venture between Genetics Institute and Johns Hopkins University. From 1985-1992, Ms. Perkins worked at Bain & Company, an international strategy consulting firm, providing advice to clients in the healthcare industry.
Ms. Perkins received her M.B.A. from Harvard Business School and her B.S. in chemical engineering from Villanova University. In addition to chairing the Infinity (NASDAQ: INFI) Board, she is on the Boards of Bruker Corporation (NASDAQ: BRKR), Massachusetts General Hospital, BIO (Biotechnology Industry Organization), the Massachusetts Biotechnology Council, and is the Vice Chairman of the Board of Project Hope. She is a past member of the Boards of Padlock Therapeutics, prior to its acquisition by Bristol-Myers Squibb, and the Massachusetts Life Science Center.
Bill Pilat, Lilly
Bill Pilat, Director of Market Research Capabilities, Lilly
Bill has 18 years of market research experience, leading secondary, qualitative, quantitative, and observational projects during his career. He recently assumed the role of Director of Market Research Capabilities at Eli Lilly, where he will be in charge of evaluating and integrating new market research techniques into the organization. Bill is known for his ability to develop innovative market research approaches to address business problems. He graduated from Bradley University and received his masters from the University of South Carolina. Bill is married, with two sons, and is a volunteer chess coach for elementary and middle school children.
Mini Pinto, Merck
Mini Pinto, Global Leader, Market Research, Oncology CBL, Merck
Josh Plumb, Intarcia Therapeutics
Josh Plumb, Senior Director, Payer Marketing, Intarcia Therapeutics
Josh Plumb is currently Senior Director of Payer Marketing at Intarcia Therapeutics, Inc. Josh is responsible for developing and implementing marketing strategies and plans for payers, IDNs, and other organized customers. Previously Josh was Market Access Director at Cubist Pharmaceuticals, leading 15 key account managers that spanned the East Coast. Spanning over a decade, Josh held positions of increasing responsibility at Cubist, from Market Access to Marketing to Analytics to Sales. Josh began his career in politics and also spent time in software. He holds an MBA from New York University’s Stern School and a Bachelor’s degree from Bucknell University.
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat founded Lifescience Dynamics in the summer of 2004. Thirteen years on, Lifescience Dynamics is privileged to boast an extraordinary worldwide customer base with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Previously, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects focusing on all aspects of the clinical development and commercialisation environments. He has also previously worked for Eli Lilly & Company, Pepsi-Cola and McDonald’s in marketing and management.
Rafaat was born in India, brought up in Oman/UAE, gained a business degree in the USA and an MBA from Manchester Business School in the UK.
Vadim Redchanskiy, Sucampo Pharmaceuticals
Vadim Redchanskiy, Associate Director, Strategic Business Insights, Forecasting & Analytics, Sucampo Pharmaceuticals
Mr. Vadim Redchanskiy joined Sucampo Pharmaceuticals in November of 2016 where he is responsible for Global Strategic Business Insights, Forecasting & Analytics. As a member of Global Strategic Marketing team he also supports management of the company’s business lead product, AMITIZA, and commercial planning for the organization commercial-stage and pipeline-stage opportunities.
Prior to joining Sucampo, Mr. Redchanskiy worked for 13 years at Eli Lilly and Company where he held different commercial and leadership roles to support commercial evaluation and forecasting of business development opportunities as well as supporting the global strategic marketing of early and late-stage pipeline programs for Diabetes, Oncology, Autoimmune and other key therapeutics areas.
Mr. Redchanskiy earned his bachelor and master degrees in Electrical Engineering from Odessa State Maritime Academy, and MBA from Indiana Institute of Technology.
Marjorie Reedy, Merck
Marjorie Reedy, Director, Global Market Research & Analytics, Merck
Marjorie Reedy is a seasoned market research professional with expertise in the pharmaceutical, over the counter and consumer packaged goods sectors. Currently, as Director of Digital & Consumer Innovation at Merck, Marjorie specializes in identifying innovative market research solutions to bring the voice of the patient and the customer to life. Since assuming this role, Marjorie has developed and socialized within Merck a range of “Best Practices” for using Market Research, including non-conscious implicit response technologies, to inform and optimize communications to the healthcare professional and patient communities.
Grace Samoil Reynolds, Celgene
Grace Samoil Reynolds, Market Insights I&I, Celgene
Grace is Market Insights I&I at Celgene. She was previously at Johnson & Johnson where she joined in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her passion is driving innovation and future thinking.
Andreia Ribeiro, Lifescience Dynamics
Andreia Ribeiro, Ph.D., Engagement Manager, Lifescience Dynamics
Andreia is an Engagement Manager at Lifescience Dynamics where she leads a variety of Market Access and competitive intelligence projects. Prior to joining the firm, Andreia worked for over 5 years at Decision Resources Group where she was most recently Director of Global Intelligence at the Market Access team. There she managed and/or collaborated in a variety of market research and market access projects and has extensive experience in global market access, HTA, payer systems, and P&R strategy across several therapeutic areas.
Andreia has a Ph.D. in chemical and biochemical engineering from the University of Maryland Baltimore County and a B.S./M.S. degree in chemical engineering from the University of Porto in Portugal. She also holds two professional certifications in biochemical regulatory engineering and biotechnology management.
Soumya Roy, Hall and Partners
Soumya Roy, Ph.D., CEO, US Health, Hall and Partners
With a background in Marketing Sciences and Finance, Soumya brings science and business together in research-based consulting. As CEO of Hall and Partners’ New York office, Soumya strategically supports Hall and Partners’ biggest global brands in building strong and long-lasting relationships with their customers.
Prior to joining Hall & Partners seven years ago, Soumya was senior vice president at Lieberman Research Worldwide working with both consumer and health brands. He’s a well-known brand thought leader, having presented at global conferences held by The Economist, Cannes Lions, TMRE and PBIRG. Soumya earned his doctorate in Marketing Sciences at Temple University.
Paul Saatsoglou, Ipsen
Paul Saatsoglou, VP Strategy/Operations-North America, Global Program Director-Worldwide, Ipsen
Paul jointed Ipsen in May 2014 after working at Onyx Pharmaceuticals furthering his career in forecasting, primary market research and analytics during his 35+ years of pharmaceutical experience.
His expertise is forecasting new product launches, through the formation of multidisciplinary launch teams, primary data collection and generation of metrics to track performance while using competitive intelligence to assess the competitive impact on launches. While driving Ipsen’s forecasting, Paul is also leading critical operational improvement, strategic projects and process improvements
Paul’s primary focus has been Oncology, Neurology and Rare diseases. He recently assisted in the launches of Samtuline Depot, Onivyde and Dysport.
Paul’s pharmaceutical experience includes roles at Eisai, BMS, J&J and Pfizer.
John Scaife, Pfizer
John Scaife, Director, Pfizer
Buddy Scalera, The Medicines Company
Buddy Scalera, Senior Director Content Strategy, Global Health Science, The Medicines Company
Buddy Scalera is the Senior Director of Content Strategy at The Medicines Company. He is the author of six published books on content, creativity, and visual storytelling.
Buddy is a content strategist and digital pioneer with over 15 years of pharmaceutical multichannel marketing experience. He is an innnovative marketing team leader delivering business results in social media, digital strategy, content engineering, website development, distance learning, mobile strategy, content creation, and digital governance.
He is a co-host on the RX Digital Marketing Podcast at http://rxdigitalmarketing.com/.
In his free time, he writes comic books for Marvel Comics and teaches classes on creating comic books.
Joel Schindler, MarketVision Research
Joel Schindler, Ph.D., Senior Vice President, Practice Lead – Oncology and Rare Disease, MarketVision Research
Dr. Joel M. Schindler brings a unique blend of experience and insight to healthcare market research. Dr. Schindler received a Ph.D. in molecular biology, held faculty positions at several medical schools and served as a program director at the National Institutes of Health (NIH). Following his NIH tenure, Joel began his career in marketing and marketing research including the last 18 years specifically in the pharmaceutical/biotechnology marketing research arena. Dr. Schindler has published extensively in both the biomedical and marketing arenas.
Chris Sepe, Bayer HealthCare
Chris Sepe, Director, Business Insights, Bayer HealthCare
Chris Sepe is a Director, Business Insights with Bayer HealthCare. In this role he is responsible for delivering objective information and insights to drive topline growth and bottom line opportunities. Chris holds a BA in Marketing from Hofstra University and a MBA in Management from Montclair State University. He previously held positions at Roche and Johnson and Johnson. Chris brings broad experience in the extended Business Insights space, including primary and secondary MR, analytics, data, CI and reporting.
Melinda Shorr, Research Partnership
Melinda B. Shorr, Ph.D., Research Director, Research Partnership
Melinda Shorr is a Director based at the Philadelphia office. She has more than 20 years’ experience in pharmaceutical market research. Prior to becoming a pharmaceutical marketing researcher, Melinda was a practicing psychologist. She has very strong experience in market understanding and communications research and has co-presented webinars on a range of topics including online communities and patient centricity.
Meridith Sigel-Willey, Novartis
Meridith Sigel-Willey, Associate Director, New Products Insights & Analytics, Novartis
Meridith Sigel-Willey is an experienced insights and analytics professional who has supported various in-line, launch and pipeline products in the areas of Ophthalmology, Rheumatology, Cardiovascular, Infectious Disease, Pain, Gastroenterology, Women’s health, Diabetes and Oncology/Hematology. Meridith is known for turning primary and secondary data into actionable insights to drive business results.
Meridith currently leads market research, forecasting, and business analytics for the early assets and business development opportunities in Ophthalmology and Rheumatology; she joined Novartis in 2016 to conduct insights and analytics for an upcoming cardiovascular launch. Prior to Novartis, Meridith worked at Shionogi Inc. supporting the entire US portfolio but spent the majority of her time working with pre-launch assets in pain and advanced antibiotics. She has also been employed at multiple market research vendors supporting various pharmaceutical customers in a variety of therapeutic areas.
Meridith began her career in Information Technology working at AT&T and IBM.
Meridith has a MBA from the University of Notre Dame and a BE from Stevens Institute of Technology. Meridith is also an alumna of WOMEN Unlimited LEAD, a leadership development program for high-potential mid-career women.
Peter Simpson, Segmedica
Peter Simpson, Principal, Segmedica
Thirty five years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has operated in most of the world’s major markets, including Japan and all of Europe. Most of his career has been spent in the Specialty Chemical, Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Management of major businesses, CFO of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.
He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice President of Consulting and Market Research at Lowe Healthcare, one of the world’s largest medical advertising agencies.
His client experience includes AstraZeneca, Schering Plough, Johnson and Johnson, TAP Pharmaceuticals, Boston Scientific, C R Bard, Pfizer, Merck and many more leading companies. He has also worked with HMO’s, Hospitals and Physicians’ Practices.
Peter’s skills include strategic planning processes, branding issues, healthcare marketing and innovative market research. In over a decade of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and facilitator. He has been researching and developing psychology based methodologies for medical market research for seven years and has developed a number of novel techniques and processes.
Shira Sinclair, Purdue Pharma
Shira Sinclair, Director, Market Research, Purdue Pharma
Shira currently leads the Market Research team at Purdue Pharma. In this role, Shira is responsible for generating and integrating in-depth data analysis and insights-driven market research to drive Purdue’s brand strategies. Shira has held various positions throughout her career within both primary and secondary data analytics which have uniquely enabled her to develop a well-rounded view of her markets. She started her career with a focus on targeting and call planning at the Michael Allen Company, a pharmaceutical consultancy, and later in Schering-Plough’s Global Business Analytics group. Prior to joining Purdue, she worked at Forest Laboratories, where she was responsible for market research and insight generation across a range of products within the respiratory and CNS portfolios. Shira holds a Bachelor of Arts in Psychology from the University of Pennsylvania, and a Masters of Business Administration from NYU-Stern.
Geoff Stamper, Bristol-Myers Squibb
Geoff Stamper, Director, Integration and Demand Planning, Bristol-Myers Squibb
Geoff Stamper has over 17 years of experience in the pharmaceutical industry, having served in a number of functional areas including development, discovery research, portfolio management, and commercial. He has spent the last 6 years in forecasting and strategic planning where he has supported both the US market and WW brand teams across a number of therapeutic areas. Currently he is the Director of Integration and Demand Planning, where he leads the team responsible for WW operational and long-term gross demand and the long-term revenue outlook.
R. Sukumar, Optimal Strategix Group
R. Sukumar, CEO, Optimal Strategix Group
• Founder of OSG; delivery of 700+ engagements, resulting in $80B of incremental revenue for clients
• Expertise in industry verticals across Life Sciences, Energy, Retail, CPG and Financial Services
• 25+ years in academia, served as the Associate Dean at the Indian School of Business
• Taught Marketing Strategy and Advanced Analytics techniques at top MBA programs including Rutgers, Thunderbird, U. Maryland, U. Houston, U. Georgia and Rice U.
• MBA and Ph.D., University of Pittsburgh in Marketing and Business Administration. B.S., Mechanical Engineering, IIT, India
John Surie, M Health
John Surie, Customer Insight Director, M Health
John is a strategic brand planner and customer insight specialist with 20 years experience in the development of insight-led international brand positioning and communications concepts. He brings a deeper, more insightful understanding of patient, healthcare provider and payer mind states and attitudes, rooted in an in-depth knowledge of the key global healthcare markets.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Dave Taylor, Inspire
Dave Taylor, Senior Director, Research, Inspire
Dave Taylor is responsible for leading the research group at Inspire. During his career in healthcare research, he has worked with 80+ brands and 33 companies across dozens of therapeutic categories to address a wide array of business questions while striving to bring forth the opportunities and obstacles that exist in these markets.
Before joining Inspire, Dave worked for a number of prominent research vendors, executing both quantitative and qualitative studies. Dave’s background also includes experience in marketing, brand promotion and business development. Dave earned his BBA in Marketing from Temple University and his MBA in Marketing at Saint Joseph’s University.
Mladen Tomich, Decision Resources Group
Mladen Tomich, Ph.D., Executive Director, Decision Resources Group
Mladen Tomich, Ph.D., is an Executive Director at Decision Resources Group (DRG) where he leads the Infectious, Niche, and Rare Diseases department. In his role Dr. Tomich manages DRG’s syndicated market research portfolio across anti-infectives and orphan drug markets, providing comprehensive data, analyses and business insights to the biopharmaceutical industry. Dr. Tomich also manages DRG’s syndicated Real World Data portfolio, spanning numerous therapeutic areas. He holds a Ph.D. in Microbiology from The University of Minnesota and completed postdoctoral studies at Columbia University. Previously, Dr. Tomich was the Director of Hospital Market Analytics at DRG’s Arlington Medical Resources. Prior to joining DRG, Dr. Tomich worked in pharmaceutical research and development at Merck and Medimmune/AstraZeneca, focusing on the discovery of new antibiotics and monoclonal antibodies for the treatment of serious bacterial infections.
Alexine Tranquada, Merck
Alexine Tranquada, Director, Global Customer and Brand Insights, Merck
Alexine Tranquada is a recognized pharmaceutical top talent with almost 20 years of experience analyzing and developing marketing strategies with entrepreneurial spirit and ownership. She is committed to optimizing performance with agility in dynamic and ambiguous environment. She has expertise in all stages of the product life cycle, multiple therapeutic areas, US and global. She has a proven history of utilizing best practices for outstanding results. She is currently leading the Global and Customer Brand Insight (GCBI) team for Merck Biosimilars Business. This business is in launch mode for the first biosimilars developed by Merck and Samsung Bioepis. Previously, Alexine was responsible for the market research and analytics for Diversified Brands and Immunology franchises. She built the capabilities of the original Diversified Brands market research function, bringing consistent high performance, deep analytical insights, high energy, efficiency and leadership skills, to develop foundational institutional building blocks for loss of exclusivity and post-patent success. Alexine held various roles of increasing responsibility including with the cardiovascular franchise (both marketing and market research), regional market research training, and Market Research Excellence.
Alexine has been with Schering-Plough and Merck for the past nine years, and was previously an Associate Vice-President at GfK. She held roles of increasing responsibility in both custom and syndicated market research, including leading the syndicated research in cardiovascular, metabolics and GI. Prior to entry in the pharmaceutical industry, Alexine worked in basic animal-model laboratory research at the University of Pittsburgh.
Alexine has a Bachelor of Science from McGill University (in Microbiology and Immunology with a minor in Management) and an MBA from the University of Pittsburgh with concentrations in Marketing and Strategy. Outside of work, Alexine is an avid runner and mother of three children, Ella (age 13), Calvin (age 10) and Miles (age 6).
Daryl Travis, Brandtrust
Daryl Travis, CEO, Brandtrust
A trusted advisor to many of the largest and best brands in the world, Daryl Travis is a rare breed of author, thought leader and highly regarded consultant. His first book Emotional Branding pioneered the idea that brands are largely about feelings not facts.
As Founder and CEO of Brandtrust, his teams apply social and behavioral science to reveal deeper human truths that solve complex brand, innovation and customer experience challenges for many global brands.
He could be described as a professor, detective, journalist, psychologist and writer all rolled into one. A colorful and engaging storyteller, Daryl speaks frequently on the power of human truths to change everything including how you think about your customers and your business. He explains how research can lead us astray or help us to gain a competitive edge. “Most research discloses what happens,” he says. “However, it often fails to reveal why it happens or the underlying emotional drivers that are critical in creating an effective strategy.” Daryl’s guiding mantra is The NINA Principle®: No Insight—No Advantage®.
Passionate about learning and understanding more about how people think, Daryl is always reading a new book—more than one hundred each year. His voracious reading helps leverage recent breakthroughs in the social sciences to improve the consumer research process, tapping into the deeper underlying emotions and nonconscious motivations critical to revealing insights.
Daryl and his wife Donnita extend his continuous learning passion as active members of Chicago’s philanthropic community, volunteering time and resources to support education and literacy programs for underprivileged children throughout the city.
Cindy Tullis, Directions Research
Cindy Tullis, Sr. Vice President, Directions Research
A former J&J veteran, Cindy has a unique understanding of how to utilize insights to drive business growth. She is the leader of the Healthcare Division at Directions and has a passion for innovation and product development. Over her career she has led multiple teams through the innovation process, resulting in a number of successful introductions in-market.
Chaitra Ujjani, Georgetown University Hospital
Chaitra Ujjani, MD, Associate Professor of Medicine, Georgetown University Hospital
Chaitra Ujjani, MD is an Associate Professor of Medicine, Division of Hematology/Oncology, at Georgetown University Hospital, Lombardi Comprehensive Cancer Center. Her focus is on novel therapies in the treatment of lymphoid malignancies. Dr. Ujjani provides care for patients with various hematologic disorders including AML.
Chaitra holds a B.S. in Psychology from University of Alabama at Birmingham and a M.D. from University of Alabama School of Medicine.
Jeet Uppal, Bristol-Myers Squibb
Jeet Uppal, Worldwide Lead – Global Market Research Capabilities, Bristol-Myers Squibb
Jeet is currently the Worldwide Lead, Market Research Capabilities & Enablement at Bristol-Myers Squibb. He leads a team of Researchers and his group responsibilities include managing tracking studies across all therapeutic areas and regions, social listening, MR agency management, knowledge management, training and best practice. Earlier he also established and led the oncology patient chart audit at BMS.
Prior to BMS, Jeet was the Global Group Director for Global Market Research at Zoetis. Jeet led a global team of market researchers and was responsible for Market Research across all species, regions and new products. Jeet joined Pfizer in 2003 as Director, Global Market Research. Pfizer spun off to Zoetis in 2012.
Jeet worked in Pfizer Human Pharmaceutical Opthalmology and Oncology disease areas. He led Pfizer Opthalmology’s market research US and worldwide teams for Glaucoma (Xalatan & Xalacom), Macular degeneration (Macugen) and New Products (Dry eye, DME, strategic evaluation of new disease areas and licensing/development opportunities). Prior to moving to Animal Health, Jeet worked in Pfizer’s Oncology TA and led market research for Oncology New Products and Business Development.
Prior to joining Pfizer, Jeet worked for 10 years in marketing and market research at premier companies including Procter & Gamble, PepsiCo International and Reliant Energy. Jeet started his market research career at Procter & Gamble, where he led core projects across P&G’s Paper, Home-Care and New Ventures business units. Jeet has led market research efforts on multiple billion dollar plus brands like Bounty, Luvs, Pampers, Cascade and Dawn, leading both established business and new ventures. Jeet led PepsiCo’s international market research for the core Pepsi brands. At Reliant Energy, Jeet led direct marketing and market research for the deregulating utility market.
Jeet received his MBA from University of Chicago with specialization in strategy and finance. He holds a Masters in Environmental Engineering from Pennsylvania State University.
Frank Wang, Novartis Oncology
Frank Wang, Lung Cancer and Melanoma Lead, Global Business Analysis, Novartis Oncology
Frank Wang has 15+ years’ experience in pharmaceutical industry mostly focusing on oncology area, with evolving responsibilities in global market research, market analytics, and forecasting. He has also been in the roles as regional brand lead in emerging growth market with Novartis Oncology. Frank also worked at EMD Serono, Aventis, HMR and Merck.
Jordan Warwood, Merck
Jordan Warwood, Associate Director Global Market Research & Analytics, Oncology Franchise, Merck
Jordan leads Merck’s Secondary Data and Analytics team within Oncology Market Research, where he has driven data evaluation and acquisition efforts for both Global and US Marketing teams. He is also a leading member of Merck’s cross-functional data evaluation and analytics team. Prior to Merck, Jordan was a Manager at ZS Associates, leading marketing and sales analytics engagements across a variety of therapy areas, including Oncology, CNS, and Diabetes. He was also a core member ZS’s Customer Centric Marketing team, focusing on advanced analytics. Jordan has an MBA from the Darden School of Business at the University of Virginia.
Colleen Welsh-Allen, Kantar Health
Colleen Welsh-Allen RN, Vice President, Qualitative Research, Kantar Health
Colleen has over 25 years of experience in the pharmaceutical and healthcare industries. A registered nurse, Colleen’s clinical experience includes Hemodialysis, Coronary Care, Infectious disease, and Critical care medicine (ICU and ER). More than fifteen years ago, Colleen decided to translate her experience as a nurse into a career in medical marketing research.
Colleen’s qualitative research has encompassed many treatment areas and research techniques. She has interviewed many segments in these therapeutic areas such as: KOLs, Physicians, NPs, PAs nurses, patients, and payers.
She is a member of the QRCA (Qualitative Research Consultants Association) and a Co-Director of the Pharmaceutical/Healthcare Committee.
As the Vice President of Qualitative Research Ms. Welsh-Allen oversees all of the qualitative the moderators and is responsible for quality control of all projects as well as moving forward innovation in qualitative research.
Mark Wiley, Aetna
Mark Wiley, Team Leader, Market Intelligence, Consumer Insights, Aetna
Mark began his career in healthcare in 2001 supporting Merck & Co. by developing key relationships with provider constituents at Baylor, Memorial Hermann and Kelsey Seybold hospital systems in Texas. His success continued as both an analyst and later as a professional market researcher informing strategy for Merck’s consumer leadership. Most recently, Mark successfully informed business development and launched multiple brands for Auxilium Pharmaceuticals (Endo). Mark currently leads the market intelligence function at AETNA and continues shaping Healthagen tactics and strategy through provider insights.
Scott Wright, Directions Research
Scott Wright, Vice President, Directions Research
Scott has a long history in pharm research. He helped lead BASES and Nielsen’s expansion into Pharmaceuticals and Medical devices in the early 2000’s. At Directions, he’s remained focused on healthcare, often mining different verticals like CPG and Finance for innovative solutions that increase insight and drive proactive decision making.